<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35287738</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Impaired glymphatic function in the early stages of disease in a TDP-43 mouse model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>17</StartPage><MedlinePgn>17</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-022-00291-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Multiple lines of evidence suggest possible impairment of the glymphatic system in amyotrophic lateral sclerosis (ALS). To investigate this, we used in vivo magnetic resonance imaging (MRI) to assess glymphatic function early in the course of disease in a transgenic mouse with doxycycline (Dox)-controlled expression of cytoplasmic human TDP-43 (hTDP-43&#x394;NLS), mimicking the key pathology implicated in ALS.</AbstractText><AbstractText Label="METHODS">Adult TDP-43 transgenic and littermate monogenic control mice underwent longitudinal multimodal MRI one and three weeks after the cessation of Dox feed, together with weekly rotarod assessments of motor performance. Glymphatic function was assessed using dynamic contrast-enhanced MRI to track the clearance of an MR contrast agent injected into the cisterna magna.</AbstractText><AbstractText Label="RESULTS">Compared to their littermate controls, TDP-43 mice exhibited progressive neurodegeneration including that within the primary motor cortex, primary somatosensory cortex and corticospinal tract, significant weight loss including gastrocnemius atrophy, and shortened telomere length. Furthermore, in the presence of this ALS-like phenotype, these mice have significantly disrupted glymphatic function.</AbstractText><AbstractText Label="CONCLUSIONS">Although the relationship between glymphatic clearance and ALS disease progression remains to be elucidated, these changes occurred very early in the disease course. This provides initial evidence to suggest that the glymphatic system might be a potential therapeutic target in the treatment of ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zamani</LastName><ForeName>Akram</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Adam K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Queensland Brain Institute, The University of Queensland, St Lucia, QLD, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rollo</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayers</LastName><ForeName>Katie L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>The Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, The University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farah</LastName><ForeName>Raysha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Terence J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>David K</ForeName><Initials>DK</Initials><Identifier Source="ORCID">0000-0002-7535-8651</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia. david.wright@monash.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016615" MajorTopicYN="N">Telomere</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059506" MajorTopicYN="N">Telomere Shortening</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">Diffusion-weighted imaging</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Telomere</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35287738</ArticleId><ArticleId IdType="pmc">PMC8922788</ArticleId><ArticleId IdType="doi">10.1186/s40035-022-00291-4</ArticleId><ArticleId IdType="pii">10.1186/s40035-022-00291-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1332&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6432913</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Lee VM, Trojanowski JQ. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med. 2011;17(11):659&#x2013;667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202652</ArticleId><ArticleId IdType="pubmed">21783422</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PS, Boutej H, Soucy G, Bareil C, Kumar S, Picher-Martel V, et al. Transmission of ALS pathogenesis by the cerebrospinal fluid. Acta Neuropathol Commun. 2020;8(1):65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206749</ArticleId><ArticleId IdType="pubmed">32381112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer RC, Chami AA, de Assis DR, Vourc'h P, Andres CR, Corcia P, et al. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? Brain. 2019;142(5):1176&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ, et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun. 2018;9(1):4220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4(147):147ra11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3551275</ArticleId><ArticleId IdType="pubmed">22896675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol. 2014;76(6):845&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4245362</ArticleId><ArticleId IdType="pubmed">25204284</ArticleId></ArticleIdList></Reference><Reference><Citation>Boentert M. Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives. Nat Sci Sleep. 2019;11:97&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6701267</ArticleId><ArticleId IdType="pubmed">31496852</ArticleId></ArticleIdList></Reference><Reference><Citation>Shokri-Kojori E, Wang GJ, Wiers CE, Demiral SB, Guo M, Kim SW, et al. beta-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci U S A. 2018;115(17):4483&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5924922</ArticleId><ArticleId IdType="pubmed">29632177</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, et al. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130(5):643&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff JJ, Lee H, Yu M, Feng T, Logan J, Nedergaard M, et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest. 2013;123(3):1299&#x2013;1309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3582150</ArticleId><ArticleId IdType="pubmed">23434588</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright DK, Liu S, van der Poel C, McDonald SJ, Brady RD, Taylor L, et al. Traumatic brain injury results in cellular, structural and functional changes resembling motor neuron disease. Cereb Cortex. 2017;27(9):4503&#x2013;4515.</Citation><ArticleIdList><ArticleId IdType="pubmed">27566977</ArticleId></ArticleIdList></Reference><Reference><Citation>Tournier JD, Smith R, Raffelt D, Tabbara R, Dhollander T, Pietsch M, et al. MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation. Neuroimage. 2019;202:116137.</Citation><ArticleIdList><ArticleId IdType="pubmed">31473352</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffelt DA, Tournier JD, Smith RE, Vaughan DN, Jackson G, Ridgway GR, et al. Investigating white matter fibre density and morphology using fixel-based analysis. Neuroimage. 2017;144(Pt A):58&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5182031</ArticleId><ArticleId IdType="pubmed">27639350</ArticleId></ArticleIdList></Reference><Reference><Citation>Mychasiuk R, Hehar H, Ma I, Esser MJ. Dietary intake alters behavioral recovery and gene expression profiles in the brain of juvenile rats that have experienced a concussion. Front Behav Neurosci. 2015;9:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4318392</ArticleId><ArticleId IdType="pubmed">25698949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright DK, O'Brien TJ, Mychasiuk R, Shultz SR. Telomere length and advanced diffusion MRI as biomarkers for repetitive mild traumatic brain injury in adolescent rats. Neuroimage Clin. 2018;18:315&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5987845</ArticleId><ArticleId IdType="pubmed">29876252</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009;44(1):83&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">18501637</ArticleId></ArticleIdList></Reference><Reference><Citation>White MA, Lin Z, Kim E, Henstridge CM, Pena Altamira E, Hunt CK, et al. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss. Acta Neuropathol Commun. 2019;7(1):166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6819591</ArticleId><ArticleId IdType="pubmed">31661035</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K. Amyotrophic lateral sclerosis&#x2013;a model of corticofugal axonal spread. Nat Rev Neurol. 2013;9(12):708&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2789838</ArticleId><ArticleId IdType="pubmed">19779148</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright DK, Symons GF, O&#x2019;Brien WT, McDonald SJ, Zamani A, Major B, et al. Diffusion imaging reveals sex differences in the white matter following sports-related concussion. Cereb Cortex. 2021;31:4411.</Citation><ArticleIdList><ArticleId IdType="pubmed">33860291</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright DK, Trezise J, Kamnaksh A, Bekdash R, Johnston LA, Ordidge R, et al. Behavioral, blood, and magnetic resonance imaging biomarkers of experimental mild traumatic brain injury. Sci Rep. 2016;6:28713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4923906</ArticleId><ArticleId IdType="pubmed">27349514</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffelt D, Tournier JD, Rose S, Ridgway GR, Henderson R, Crozier S, et al. Apparent fibre density: a novel measure for the analysis of diffusion-weighted magnetic resonance images. Neuroimage. 2012;59(4):3976&#x2013;3994.</Citation><ArticleIdList><ArticleId IdType="pubmed">22036682</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffelt DA, Smith RE, Ridgway GR, Tournier JD, Vaughan DN, Rose S, et al. Connectivity-based fixel enhancement: whole-brain statistical analysis of diffusion MRI measures in the presence of crossing fibres. Neuroimage. 2015;117:40&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4528070</ArticleId><ArticleId IdType="pubmed">26004503</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Q, Zhang L, Ding G, Davoodi-Bojd E, Li Q, Li L, et al. Impairment of the glymphatic system after diabetes. J Cereb Blood Flow Metab. 2017;37(4):1326&#x2013;1337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5453454</ArticleId><ArticleId IdType="pubmed">27306755</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaberel T, Gakuba C, Goulay R, De Lizarrondo SM, Hanouz JL, Emery E, et al. Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis? Stroke. 2014;45(10):3092&#x2013;3096.</Citation><ArticleIdList><ArticleId IdType="pubmed">25190438</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X, Qiao J, Kulkarni P, Harding IC, Ebong E, Ferris CF. Imaging the effect of the circadian light-dark cycle on the glymphatic system in awake rats. Proc Natl Acad Sci U S A. 2020;117(1):668&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6955326</ArticleId><ArticleId IdType="pubmed">31848247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hablitz LM, Vinitsky HS, Sun Q, Staeger FF, Sigurdsson B, Mortensen KN, et al. Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia. Sci Adv. 2019;5(2):eaav5447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6392807</ArticleId><ArticleId IdType="pubmed">30820460</ArticleId></ArticleIdList></Reference><Reference><Citation>Benveniste H, Lee H, Ding F, Sun Q, Al-Bizri E, Makaryus R, et al. Anesthesia with dexmedetomidine and low-dose isoflurane increases solute transport via the glymphatic pathway in rat brain when compared with high-dose isoflurane. Anesthesiology. 2017;127(6):976&#x2013;988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5685871</ArticleId><ArticleId IdType="pubmed">28938276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozturk BO, Monte B, Koundal S, Dai F, Benveniste H, Lee H. Disparate volumetric fluid shifts across cerebral tissue compartments with two different anesthetics. Fluids Barriers CNS. 2021;18(1):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7788828</ArticleId><ArticleId IdType="pubmed">33407650</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3880190</ArticleId><ArticleId IdType="pubmed">24136970</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulla S, Machts J, Kaufmann J, Patrick K, Kollewe K, Dengler R, et al. Hippocampal degeneration in patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35(11):2639&#x2013;2645.</Citation><ArticleIdList><ArticleId IdType="pubmed">25004891</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T, Uchihara T, Arai N, Mizutani T, Iwata M. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease. Acta Neuropathol. 2009;117(1):35&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">19002475</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, Verstraete E, Walhout R, Schmidt R, Hendrikse J, Veldink JH, et al. Subcortical structures in amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36(2):1075&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">25281019</ArticleId></ArticleIdList></Reference><Reference><Citation>Quadri Z, Johnson N, Zamudio F, Miller A, Peters M, Smeltzer S, et al. Overexpression of human wtTDP-43 causes impairment in hippocampal plasticity and behavioral deficits in CAMKII-tTa transgenic mouse model. Mol Cell Neurosci. 2020;102:103418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7505208</ArticleId><ArticleId IdType="pubmed">31705957</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Tripathy K, Restrepo CR, Ge G, Xu Y, Kwong LK, et al. An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice. Hum Mol Genet. 2015;24(25):7241&#x2013;7254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5007600</ArticleId><ArticleId IdType="pubmed">26476406</ArticleId></ArticleIdList></Reference><Reference><Citation>Mito R, Raffelt D, Dhollander T, Vaughan DN, Tournier JD, Salvado O, et al. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment. Brain. 2018;141(3):888&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">29309541</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L, Tang X, Luo C, Liu D, Zhang Y, Zhang J. Fiber-specific white matter reductions in amyotrophic lateral sclerosis. Neuroimage Clin. 2020;28:102516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7724379</ArticleId><ArticleId IdType="pubmed">33396003</ArticleId></ArticleIdList></Reference><Reference><Citation>Krauss R, Bosanac T, Devraj R, Engber T, Hughes RO. Axons matter: the promise of treating neurodegenerative disorders by targeting SARM1-mediated axonal degeneration. Trends Pharmacol Sci. 2020;41(4):281&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">32107050</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185(2):232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair G, Carew JD, Usher S, Lu D, Hu XP, Benatar M. Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis. Neuroimage. 2010;53(2):576&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pubmed">20600964</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollari E, Savchenko E, Jaronen M, Kanninen K, Malm T, Wojciechowski S, et al. Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis. J Neuroinflammation. 2011;8:74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146845</ArticleId><ArticleId IdType="pubmed">21711557</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee R, Mosley RL, Reynolds AD, Dhar A, Jackson-Lewis V, Gordon PH, et al. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLOS One. 2008;3(7):e2740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2481277</ArticleId><ArticleId IdType="pubmed">18648532</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Lee JD, Woodruff TM, Henderson RD. The peripheral immune system and amyotrophic lateral sclerosis. Front Neurol. 2020;11:279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186478</ArticleId><ArticleId IdType="pubmed">32373052</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitan E, Hutchison ER, Mattson MP. Telomere shortening in neurological disorders: an abundance of unanswered questions. Trends Neurosci. 2014;37(5):256&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4008659</ArticleId><ArticleId IdType="pubmed">24698125</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005;6(8):611&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">16136653</ArticleId></ArticleIdList></Reference><Reference><Citation>Symons GF, Clough M, O&#x2019;Brien WT, Ernest J, Salberg S, Costello D, et al. Shortened telomeres and serum protein biomarker abnormalities in collision sport athletes regardless of concussion history and sex. J Concussion. 2020;4:2059700220975609.</Citation></Reference><Reference><Citation>Sun M, Brady RD, Casillas-Espinosa PM, Wright DK, Semple BD, Kim HA, et al. Aged rats have an altered immune response and worse outcomes after traumatic brain injury. Brain Behav Immun. 2019;80:536&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">31039431</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller Madrid A, Rasmussen KL, Rode L, Frikke-Schmidt R, Nordestgaard BG, Bojesen SE. Observational and genetic studies of short telomeres and Alzheimer's disease in 67,000 and 152,000 individuals: a Mendelian randomization study. Eur J Epidemiol. 2020;35(2):147&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">31564046</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarabino D, Broggio E, Gambina G, Corbo RM. Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients. Exp Gerontol. 2017;98:143&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">28827085</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Annunziata A, Fiorentino G, Manfellotto F, D'Alessandro R, Marino R, et al. Telomerase expression in amyotrophic lateral sclerosis (ALS) patients. J Hum Genet. 2014;59(10):555&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">25142509</ArticleId></ArticleIdList></Reference><Reference><Citation>Eitan E, Tichon A, Gazit A, Gitler D, Slavin S, Priel E. Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis. EMBO Mol Med. 2012;4(4):313&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3376858</ArticleId><ArticleId IdType="pubmed">22351600</ArticleId></ArticleIdList></Reference><Reference><Citation>Linkus B, Wiesner D, Messner M, Karabatsiakis A, Scheffold A, Rudolph KL, et al. Telomere shortening leads to earlier age of onset in ALS mice. Aging. 2016;8(2):382&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4789589</ArticleId><ArticleId IdType="pubmed">26978042</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>